Skip to main content
OpenTrials

Clinical trial condition

Actinomycetales Infections

Explore clinical trials studying Actinomycetales Infections. Study availability and eligibility vary by location and protocol.

1,556 public trials 161 recruiting studies
Refine in advanced search Browse all conditions

Actinomycetales Infections trial results

Completed

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

NCT01859923

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • De La Salle Health Sciences Institute Dasmariñas, Cavite, Philippines
  • Lung Center of the Philippines Quezon City, National Capital Region, Philippines
  • Brooklyn Chest Hospital Ysterplaat, Cape Town, South Africa
View Trial Details
Completed

To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children

NCT04618939

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • Changwon Fatima Hospital Changwon, South Korea
  • The Catholic University of Korea Daejeon St. Mary's Hospital Daejeon, South Korea
  • The Catholic University of Korea Incheon St. Mary's Hospital Incheon, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Completed

Pilot Clinical Trial of PRS TB Regimen I - Phase II

NCT03561753

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • Eighty-fifth Hospital of PLA Shanghai, China
  • Shanghai Public Health Clinical Center Shanghai, China Shanghai, China
  • Shanghai Center for Disease Control and Prevention Shanghai, China
  • Shanghai Pulmonary Hospital, Shanghai, China Shanghai, China
View Trial Details
Completed

Digital Health Promotion in Iringa, Tanzania

NCT03808597

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +23 more
Locations
  • National Institute for Medical Research / Muhimbili University Dar es Salaam, Dar, Tanzania
  • Idodi Iringa, Tanzania
  • Izazi Iringa, Tanzania
  • Kimande Iringa, Tanzania
View Trial Details
Completed

Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects

NCT03311659

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations
  • GSK Investigational Site Barnaul, Russia
  • GSK Investigational Site Gatchina, Russia
  • GSK Investigational Site Moscow, Russia
  • GSK Investigational Site Moscow, Russia
View Trial Details
Completed

Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

NCT04208789

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations
  • Kanudjoso Djatiwibowo General Hospital Balikpapan, East Kalimantan, Indonesia
  • Tarakan General Hospital Tarakan, North Kalimantan, Indonesia
  • Wahidin Sudirohusodo General Hospital Makassar, South Sulawesi, Indonesia
  • Labuang Baji General Hospital Makassar, South Sulawesi, Indonesia
View Trial Details

Related conditions